| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Mrz―30 |
Analysis of some polymorphic <i>IL-6</i>, <i>IL-10</i> gene variants in individuals with psychoneurological manifestations of long COVID |
Anna V. Sedykh, Kristina Y. Shchepotkina, Yulia V. Ostankova, Vadim V. Rassokhin, Ekaterina V. Zagalskaya, Anastasia A. Knizhnikova, et al. (+3) Anna O. Norka, Natalia V. Halinouskaya, Nikolay A. Belyakov |
| 2 |
[GO] |
2026―Mrz―30 |
Genotypic diversity and primary drug resistance of <i>Mycobacterium tuberculosis</i> strains in the Novgorod Region of Russia in the COVID-19 pre-pandemic period |
A. A. Vyazovaya, A. Y. Chilikina, A. G. Petrova, O. P. Fedotova, E. A. Yukhnova, A. A. Gerasimova, et al. (+4) N. S. Solovieva, V. Y. Zhuravlev, I. V. Mokrousov, A. V. Karpov |
| 3 |
[GO] |
2026―Mrz―30 |
SSA post-analysis of COVID-19 incidence magnitude in Novosibirsk Region |
Viktoriya S. Petrakova |
| 4 |
[GO] |
2026―Jan―20 |
The impact of COVID-19 on respiratory tract microbiota pattern in patients with severe pneumonia |
M. O. Zolotov, A. V. Kozlov, Liliya R. Shafigullina, A. V. Lyamin |
| 5 |
[GO] |
2025―Dez―08 |
Severity-related differences on response of antioxidant defense system in COVID-19 patients |
M. Shohrati, Mahvash Jafari, M. Sadrzadeh, H. Ebrahiminezhad, M. Ghanei |
| 6 |
[GO] |
2025―Jul―02 |
ASSESSMENT OF THE ABILITY OF SARS-COV-2 STRAINS OF GENETIC VARIANTS B.1.1 AND JN.1 TO EVADE NEUTRALIZING ANTIBODIES FROM 2020 AND 2023 CONVALESCENT PATIENTS |
Stepan Alexandrovich Pyankov, Anna Vladimirovna Zaykovskaya, Anna Vyacheslavovna Rybel, Sergey Alexandrovich Bodnev, Oleg Victorovich Pyankov |
| 7 |
[GO] |
2025―Jul―02 |
PATHOGENESIS OF AUTOIMMUNE INFLAMMATION IN COVID-19: A LITERATURE REVIEW |
Alexandr Valeryanovich Volkov, Tatiana Ruzhentsova |
| 8 |
[GO] |
2025―Jun―04 |
DESIGNING A MULTI-EPITOPE VACCINE AGAINST SARS-COV2: AN IMMUNOINFORMATIC APPROACH |
Vahab Alamdari-palangi, Zeinab Dehghan, Mehdi Kian, Saghar Zonar, Jafar Fallahi, Mohsen Sisakht, et al. (+2) Sahar Khajeh, Vahid Razban |
| 9 |
[GO] |
2025―Jun―04 |
THE ROLE OF GENETIC HEMOSTASIS GENE VARIANTS IN THE DEVELOPMENT OF VENOUS THROMBOSIS IN PATIENTS WITH ATHEROSCLEROSIS AFTER COVID-19 INFECTION |
Oleg A Perevezentsev, Ilgar Salekh Mamedov, Dmitriy V. Burtsev |
| 10 |
[GO] |
2025―Apr―30 |
Cytokine profile of COVID-19 convalescent plasma and its relationship to outcome of treated patients |
Michael P. Potapnev, A. V. Maximovich, I. A. Dunayeu, L. M. Hushchina, F. N. Karpenko |
| 11 |
[GO] |
2024―Dez―09 |
ARVI PATTERN IN THE NORTHWEST FEDERAL DISTRICT DURING THE COVID-19 PANDEMIC (2021-2022) |
V A Sbarzaglia, A S Gladkikh, D M Milichkina, A V Bachevskaya, М R Popova, E A Cherepanova, et al. (+2) V G Dedkov, A A Totolian |
| 12 |
[GO] |
2024―Dez―09 |
EPIDEMIOLOGICAL TRENDS IN ALGERIAN WILAYAS DURING THE COVID-19 PANDEMIC |
Zineb HARFOUCHE, Amine AMIMOUR |
| 13 |
[GO] |
2024―Dez―09 |
ARE HIV-INFECTED PEOPLE AT RISK GROUP FOR COVID-19 MORBIDITY AND SEVERE COURSE? |
Victor I. Sergevnin, Marina Vladimirovna Rozhkova, Rashid Gabbasovich Gibadulin |
| 14 |
[GO] |
2024―Dez―09 |
A RELATION BETWEEN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSwNP) AND COVID-19 COURSE |
Elena Lyubimova, Elena Savlevich, Alexander Zurochka, Elizaveta Mitrofanova |
| 15 |
[GO] |
2024―Dez―09 |
IMMUNOGENETIC MARKERS OF COVID-19 SEVERITY IN ST. PETERSBURG RESIDENTS |
Elena Vital’evna Kuzmich, Irina Evgenievna Pavlova, Tatyana Valentinovna Glazanova, Elena Romanovna Shilova, Ludmila Nikolaevna Bubnova |
| 16 |
[GO] |
2024―Dez―09 |
ASSESSMENT OF INFLUENZA AND COVID-19 VACCINE EPIDEMIOLOGIC EFFICACY IN THE 2020-2021, 2021-2022, 2022-2023 SEASONS IN NOVOSIBIRSK |
Tereza A. Saroyan, Olga G. Kurskaya, Maria Vladimirovna Solomatina, Kirill Alexandrovich Sharshov, Аlexandr M. Shestopalov, Mariana K. Erofeeva, et al. (+3) Marina A. Stukova, Zhanna V. Buzitskaya, Dmitry A. Lioznov |
| 17 |
[GO] |
2024―Dez―09 |
ROLE OF TOLL-LIKE RECEPTOR POLYMORPHISMS IN THE DEVELOPMENT OF EXTREMELY SEVERE COVID-19 WITH FATAL OUTCOME |
Ludmila Ashchina, Nadezhda Ivanovna Baranova, Oksana Alexandrovna Kulieva, Alexandra Igorevna Bolgova |
| 18 |
[GO] |
2024―Dez―09 |
EXPERIENCE OF USING THE PREPARATION GLUCAFERON WITHIN A COMBINATION THERAPY OF MODERATE SARS-COV-2-CAUSED NOVEL CORONAVIRUS INFECTION |
Nikita O. Shatyy, Evgeniya V. Bezrukova, Valentina G. Konusova, Evgeniy V. Vorobeychikov, Sergey A. Artyshkin, Andrey S. Simbircev |
| 19 |
[GO] |
2024―Dez―09 |
SAFETY AND SPECIFIC ACTIVITY OF THE RECOMBINANT SARS-COV-2 (CORONADERM-PS) ALLERGEN BASED ON PHASE I-II CLINICAL TRIAL RESULTS |
Tikhon V. Savin, Angelica M. Milichkina, Alexey A. Krasnov, Raisa N. Kuznetsova, Elena E. Shchederkina, Alena V. Svarval, et al. (+15) Alena А. Sharova, Diana E. Reingardt, Yulia V. Ostankova, Alexandra V. Gubanova, Olga A. Petrova, Oyuna B. Zhimbaeva, Alexandra P. Razumovskaya, Irina V. Drozd, Artem А. Rubinstein, Andrey S. Trulioff, Igor V. Kudryavtsev, Vladimir V. Kopat, Ilya V. Dukhovlinov, Andrey S. Simbirtsev, Areg A. Totolian |
| 20 |
[GO] |
2024―Dez―09 |
THE IMPACT OF CONCOMITANT DISEASES DURING SARS-COV-2 INFECTION IN RESIDENTS OF KAZAKHSTAN |
Mayra Zangarovna Ashirova, Gulzhan Narkenovna Abuova, Bibigul Toelegenovna Seytkhanova |
| 21 |
[GO] |
2024―Dez―09 |
ANTIGENIC FEATURES OF THE STRAINS SARS-COV-2 OF OMICRON SUBLINES ASSESSED BY HYPERIMMUNE MOUSE SERUM NEUTRALISATION |
Anna Vladimirovna Zaykovskaya, Vasily Aleksandrovich Evseenko, Sergey Evgenievich Olkin, Oleg Victorovich Pyankov |
| 22 |
[GO] |
2024―Dez―09 |
GENOMIC DIVERSITY OF TOXIGENIC VIBRIO CHOLERAE O1 BIOVAR EL TOR STRAINS ISOLATED DURING THREE WAVES OF THE 7TH CHOLERA PANDEMIC |
Nina Ivanovna Smirnova, Darya Alexandrovna Rybal’chenko, Yulii Vladislavovich Lozovskiy, Yaroslav Mikhailovich Krasnov, Elena Yur'evna Schelkanova, Andrej Vital'evich Fedorov, Vladimir Viktorovich Kutyrev |
| 23 |
[GO] |
2024―Okt―30 |
New promising antiseptics for individual antiviral protection against seasonal infections including COVID-19 |
S. A. Lepekhova, G. E. Grigor’ev, Ilya S. Kurganskiy |
| 24 |
[GO] |
2024―Okt―30 |
Post-vaccination immunity and pneumonia incidence in medical workers in response to various flu vaccination regimens between the 1st and 2nd peaks of COVID-19 morbidity |
Mikhail Petrovich Kostinov, N. Yu. Nastaeva, N. F. Nikityuk, K. V. Mashilov, A. A. Khasanova, I. L. Solovyeva, et al. (+7) N. P. Andreeva, Yu. А. Li, V. B. Polishchuk, Andrey V. Linok, M. N. Loktionova, A. M. Kostinova, I. A. Khrapunova |
| 25 |
[GO] |
2024―Okt―30 |
Altered leukocyte blood count in COVID-19 pandemic period |
Sergey N. Kostarev, T. G. Sereda |
| 26 |
[GO] |
2024―Okt―30 |
The effect of a new coronavirus infection on hemogram parameters in the early convalescence period of patients with coronary heart disease |
Nikolay M. Agarkov, T. I. Yakunchenko, O. I. Okhotnikov, K. F. Makkonen, M. V. Alymova |
| 27 |
[GO] |
2024―Aug―05 |
Dental and microbiological status of COVID-19 convalescent patients with simple marginal gingivitis |
A. V. Lyamin, A. V. Vinnik, M. A. Postnikov, S. V. Vinnik, N. V. Popov, D. V. Alekseev |
| 28 |
[GO] |
2024―Aug―05 |
Assessing molecular genetic and immunological predictors of COVID-19 course in healthcare worker risk group |
I. D. Reshetnikova, Yu. A. Tyurin, I. G. Mustafin, E. V. Agafonova, N. D. Shaуkhrazieva |
| 29 |
[GO] |
2024―Aug―05 |
Features of T-cell and humoral immunity of patients with acute coronary syndrome, with and without COVID-19, depending on/peripheral blood B-lymphocytes with the phenotype CD3-CD19+CD5+ level |
E. A. Safronova, L. V. Ryabova, Александр Vladimirovich Zurochka, M. А. Dobrynina |
| 30 |
[GO] |
2024―Aug―05 |
The association between the history of supplement use (vitamin or mineral) and COVID-19 disease in the persian cohort population |
F. Ghorat, A. Ganj Bakhsh, R. Ataee, R. Borghabani, Z. Jalambadani |
| 31 |
[GO] |
2024―Aug―05 |
Forecasting infection fatality rate of COVID-19: measuring the efficiency of several hybrid models |
D. Seba, K. Belaide |
| 32 |
[GO] |
2024―Aug―05 |
Autoimmune disorders in patients with granulomatosis diseases after COVID-19: T- and B-cells subsets function |
A. A. Starshinova, I. V. Kudryavtsev, A. A. Rubinstein, A. Malkova, H. Ling, M. Zhuang, et al. (+3) A. Yu. Starshinova, I. F. Dovgaluk, D. A. Kudlay |
| 33 |
[GO] |
2024―Aug―05 |
Immune status of patients with community-acquired pneumonia associated with a new coronavirus infection and other viral and bacterial pathogens |
I. A. Ivanova, A. V. Filippenko, N. V. Pavlovich, N. V. Aronova, M. V. Tsimbalistova, A. S. Anisimova, et al. (+4) N. D. Omelchenko, A. A. Trufanova, O. S. Chemisova, A. K. Noskov |
| 34 |
[GO] |
2024―Aug―05 |
Coronavirus spike protein fragment-containing chimeric virus-like particles stimulate human dendritic cell maturation |
V. Yu. Talayev, D. V. Novikov, I. Ye. Zaichenko, M. V. Svetlova, E. V. Voronina, O. N. Babaykina, et al. (+5) V. A. Lapin, D. A. Melentiev, N. A. Novikova, A. Yu. Kashnikov, V. V. Novikov |
| 35 |
[GO] |
2024―Aug―05 |
Experimentally investigated “CoronaDerm-PS”-driven SARS-CoV-2-specific cellular immunity and safety |
T. V. Savin, V. V. Kopat, A. A. Riabchenkova, E. L. Chirak, E. R. Chirak, A. I. Saenko, et al. (+8) I. V. Dukhovlinov, G. M. Sysoeva, S. G. Gamaley, G. G. Shimina, O. S. Taranov, E. D. Danilenko, A. S. Simbirtsev, A. A. Totolian |
| 36 |
[GO] |
2024―Jul―28 |
Algorithm for assessing the level of T cell immune response against SARS-CoV-2 and the results of its application in unvaccinated and vaccinated people who have been infected with COVID-19 |
M. S. Blyakher, Irina M. Fedorova, S. I. Koteleva, I. V. Kapustin, E. A. Tulskaya, Z. K. Ramazanova, et al. (+4) E. E. Odintsov, S. V. Sandalova, L. I. Novikova, S. S. Bochkareva |
| 37 |
[GO] |
2024―Jul―28 |
Comparative assessment of interferon activity in influenza and COVID-19 |
Tatiana P. Ospelnikova, O. A. Svitich, F. I. Ershov |
| 38 |
[GO] |
2024―Jul―28 |
IL-6 and IL-18 cytokine traps in COVID-19 |
A. A. Korotaeva, Elena V. Samoilova, D. A. Chepurnova, N. V. Pogosova, D. T. Kuchiev, F. N. Paleev |
| 39 |
[GO] |
2024―Jul―28 |
Laboratory blood markers in COVID-19 and their connection to Viral variant |
Zoya R. Korobova, N. E. Liubimova, N. A. Arsentieva, M. S. Zhebeleva, E. I. Chernykh, V. V. Davletshina, et al. (+2) V. A. Kashchenko, A. A. Totolian |
| 40 |
[GO] |
2024―Jul―28 |
Expression of pro-inflammatory cytokines (IL-18, IL-33) at the level of the mucous membrane, the entry point of infection, in persons who have experienced COVID-19 disease |
Nadezhda D. Rasskazova, N. D. Abramova, T. D. Soshchenko, N. O. Kalyuzhnaya, E. A. Meremianina, M. N. Shatokhin, T. A. Zaitseva |
| 41 |
[GO] |
2024―Jul―28 |
Balance of pro- and anti-inflammatory cytokines in young patients who passed active Immunization against SARS-CoV-2 during the COVID-19 Pandemic |
Yulia A. Li, M. N. Dmitrachenko, E. V. Markelova, I. B. Korolev, M. P. Kostinov, L. I. Bondar |
| 42 |
[GO] |
2024―Jul―28 |
Characteristics of virus-specific immunological reactions following COVID-19 vaccination in heart transplant recipients |
Marina M. Zafranskaya, D. B. Nizheharodava, O. G. Shatova, I. I. Russkih, A. V. Velichko, M. I. Vanslau, et al. (+4) S. F. Novitskaya, T. L. Denisevich, M. G. Kolyadko, E. K. Kurlyanskaya |
| 43 |
[GO] |
2024―Jul―28 |
Broncho-obstructive syndrome and the enzymes of cellular energy metabolism after coronavirus infection |
Ninel I. Kosyakova, M. V. Akulenko |
| 44 |
[GO] |
2024―Jul―28 |
Blood cytokines as potential predictors of the development of SARS-CoV-2 associated pneumonia in patients with stage II ESSENTIAL hypertension |
Olga A. Radaeva, A. S. Simbirtsev, M. S. Iskandyarova, E. V. Negodnova, V. V. Kulyapkin, K. A. Krasnoglazova, V. V. Eremeev |
| 45 |
[GO] |
2024―Jul―28 |
Plasmablast response during acute SARS-CoV-2 infection |
Maria G. Byazrova, M. M. Sukhova, A. A. Mikhailov, A. F. Romanova, G. M. Yusubaliyeva, A. V. Filatov |
| 46 |
[GO] |
2024―Apr―28 |
Differences in complete blood count parameters in patients with COVID-19 diagnosis based on vaccination status (literature review) |
A. V. Konyuhov, A. M. Kostinova, M. N. Loktionova, M. P. Kostinov, A. S. Pechenik |
| 47 |
[GO] |
2024―Apr―28 |
Comparatively analyzed pattern of Delta and Omicron SARS-CoV-2 genovariant dominated COVID-19 incidence in the population of the Saratov region |
A. A. Zimirova, V. E. Kuklev, V. A. Safronov, I. N. Vyatkin |
| 48 |
[GO] |
2024―Apr―28 |
Geographical distribution of COVID-19 infection across Saudi Arabia |
H.M. Aldossari, A. Abdul Salam |
| 49 |
[GO] |
2024―Apr―28 |
Level of influenza virus strain antibodies in healthy vaccinated people at the end of the COVID-19 pandemic |
S. V. Iushkova, M. P. Kostinov, L. S. Gladkova, A. A. Kameleva, A. S. Kachnova, A. M. Kostinova, et al. (+6) I. L. Solovyeva, N. P. Andreeva, Yu. A. Dagil, N. Yu. Nastaeva, N. O. Kryukova, M. N. Loktionova |
| 50 |
[GO] |
2024―Apr―28 |
Sustained immunological memory to SARS-CoV-2 antigens. Three years of observation |
Z. E. Afridonova, A. P. Toptygina, E. L. Semikina |
| 51 |
[GO] |
2024―Apr―28 |
Investigating SARS-CoV-2 virion material trafficking in syrian hamster neocortecal neurons |
S. V. Chepur, N. M. Paramonova, I. A. Myasnikova, N. N. Pluzhnikov, M. A. Tyunin, B. A. Kanevsky, N. S. Ilyinsky |
| 52 |
[GO] |
2024―Feb―01 |
The impact of polymorphic variants of interferon receptor genes on COVID-19 severity and antibiotic resistance |
E. A. Krieger, O. V. Samodova, O. A. Svitich, R. V. Samoilikov, E. A. Meremianina, L. V. Ivanova, et al. (+7) N. A. Bebyakova, E. N. Ilina, A. V. Pavlenko, Yu. I. Esin, A. L. Arkhipova, S. N. Kovalchuk, A. V. Kudryavtsev |
| 53 |
[GO] |
2024―Feb―01 |
Monitoring of coronavirus infection in the kyrgyz population |
A. Yu. Popova, V S. Smirnov, O. T. Kasymov, S. S. Egorova, Z. S. Nurmatov, I. V. Drozd, et al. (+13) A. M. Milichkina, V Yu. Smolensky, Z. N. Nuridinova, V. A. Ivanov, G. Z. Sattarova, E. S. Ramsay, B. I. Dzhangaziev, E. V. Zueva, U. U. Arabiy, V. G. Drobyshevskaya, O. B. Zhimbaeva, A. P. Razumovskaya, A. A. Totolian |
| 54 |
[GO] |
2024―Feb―01 |
Microbial associations for pneumonia causative agents and level of their resistance to antimicrobial drugs during a new coronavirus infection pandemic |
O. N. Kolotova, L. V. Kataeva, A. A. Vakarina, T. F. Stepanova, K. B. Stepanova |
| 55 |
[GO] |
2023―Nov―15 |
EFFECT THE PRE-EXPOSURE PROPHYLACTIC OF HYDROXYCHLOROQUINE ON SEVERE COVID-19 DISEASE: A RANDOMIZED CONTROLLED TRIAL |
Mahnaz Valizadeh, Termeh Tarjoman, Behnam Farhoudi, Arezoo Chouhdari, Masoumeh Mesgarian, SeyedAhmad SeyedAlinaghi, et al. (+7) Mehrangiz Zangeneh, Zahra Hanifezadeh, Hesam Adain Atashi, Hamidreza Massumi naini, Shahla Abolghasemi, Manije Dezfulinejad, Shima Haghani |
| 56 |
[GO] |
2023―Nov―15 |
FROM CORONAVIRUSES TO CORONAVIRUSES |
Irina V. Kiseleva, Tamila D. Musaeva |
| 57 |
[GO] |
2023―Okt―20 |
AN UMBRELLA REVIEW ON TREATMENTS AND THERAPEUTIC OPTIONS FOR COVID-19 |
SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Ayoob Molla, Pegah Mirzapour, Ramin Shahidi, Haleh Siami, et al. (+6) Farid Farahani Rad, Faeze Abbaspour, Navid Mozafari, Kamal Fakhredini, Esmaeil Mehraeen, Omid Dadras |
| 58 |
[GO] |
2023―Okt―20 |
The molecular mimicry and COVID-19 |
Veronika Zorina |
| 59 |
[GO] |
2023―Okt―20 |
COMORBIDITIES IN COVID-19 AND CT-SEMIOTICS OF INPATIENTS |
Antonina Viktorovna Titova, Ulyana Konstantinovna Givoyno, Tatiana Petrova Denisova |
| 60 |
[GO] |
2023―Okt―20 |
ASSESSMENT OF TREC AND KREC LEVELS IN COVID-19 PATIENTS WITH VARYING DISEASE SEVERITY |
Мария Alexandrovna Saitgalina, Yulia Vladimirovna Ostankova, Natalia Alexandrovna Arsentieva, Zoya Romanovna Korobova, Natalia Evgenievna Liubimova, Victor Anatolievich Kashchenko, et al. (+5) Alexandr Nicolaevich Kulikov, Dmitry Edyardovich Pevtsov, Oksana Vladimirovna Stanevich, Ekaterina Ivanovna Chernykh, Areg Artemovich Totolian |
| 61 |
[GO] |
2023―Aug―21 |
PROBIOTICS IN PREVENTION AND TREATMENT OF COVID-19: A SYSTEMATIC REVIEW OF CURRENT EVIDENCE |
SeyedAhmad SeyedAlinaghi, Ramin Shahidi, Arian Afzalian, Parinaz Paranjkhoo, Kobra Ghorbanzadeh, Hengameh Mojdeganlou, et al. (+10) Armin Razi, Paniz Mojdeganlou, Mohsen Dashti, Sahar Nooralioghli Parikhani, Afsaneh Ghasemzadeh, Zahra Pashaei, Amirali Karimi, Esmaeil Mehraeen, Daniel Hackett, Ahmadi Sepide |
| 62 |
[GO] |
2023―Aug―21 |
Development of a structure and strain-producer E. coli of an antigen containing sequences of N, S, M, E proteins of the SARS-COV-2 coronavirus |
Vladimir Vladislavovich Kopat, Anastasia Andreevna Riabchenkova, Elizaveta Romanovna Chirak, Evgenii Leonidovich Chirak, Anna Igorevna Saenko, Nikolai Nikolaevich Kolmakov, et al. (+3) Ilya Vladimirovich Dukhovlinov, Andrey Semenovich Simbirtsev, Areg Artemovich Totolian |
| 63 |
[GO] |
2023―Aug―21 |
Optimization and validation of flow cytometry method for quantification of SARS-COV-2 antigen reactive T-cells |
Olga M. Strizhakova, Andrey S. Pershin, Alexander A. Kazarov, Ivan V. Lyagoskin, Yana A. Bahareva, Alexander P. Vasil'ev, et al. (+4) Yulia A. Nikonova, Irina Yu. Egorova, Rahim R. Shukurov, Ravil A. Khamitov |
| 64 |
[GO] |
2023―Aug―21 |
EVOLUTION OF HERD SARS-COV-2 HUMORAL IMMUNITY IN THE REPUBLIC OF BELARUS |
Anna Yurievna Popova, Viacheslav Сергеевич Smirnov, Svetlana Alexandrovna Egorova, Alexander Alexandrovich Tarasenko, Alla Mikhailovna Dashkevich, Angelica Marsovna Milichkina, et al. (+18) Angela Leonidovna Skuranovich, Irina Victorovna Drozd, Elena Viktorovna Zueva, Elena Olegovna Samoilovich, Valery Andreevich Ivanov, Edward Smith Ramsay, Alexandra Valerievna Gubanova, Victoria Georgievna Drobyshevskaya, Oyuna Bayarovna Zhimbaeva, Olga Aleksandrovna Petrova, Alexandra Petrovna Razumovskaya, Inna Alexandrovna Karaban, Tamara Vasilievna Amvrosyeva, Natalya Petrovna Shmeleva, Lyudmila Vladimirovna Rubanik, Alina Mikhailovna Dronina, Areg Artyomovich Totolian, Irina Nikolaevna Glinskaya |
| 65 |
[GO] |
2023―Aug―06 |
A relation between specific immune status indicators and activity of “lipid peroxidation - antioxidant defense” system in COVID-19 neonates |
Lyubov V. Rychkova, Marina A. Darenskaya, Alla G. Petrova, Natali V. Semenova, Ekaterina V. Moskaleva, Sergey I. Kolesnikov, et al. (+2) Anastasya S. Vanyarkina, Lyubov I. Kolesnikova |
| 66 |
[GO] |
2023―Aug―06 |
Antibiotics hypersensitivity reactions during COVID-19 pandemic |
Zaruhi G. Kalikyan |
| 67 |
[GO] |
2023―Aug―06 |
Evaluation of virus-neutralizing antibody level after novel coronavirus infection COVID-19: development of an instant assay assessing protective antibodies using a pseudovirus-based reaction |
Andrey A. Funtikov, Наталия A. Litvinova, Evgenii V. Zuev, Sergey V. Kulemzin, Rachim R. Shukurov |
| 68 |
[GO] |
2023―Apr―01 |
Features of lymphocyte subset composition in neonates born to mothers suffered from COVID-19 at different stages of pregnancy |
Evgeniya V. Inviyaeva, Julia A. Kosolapova, Lyubov V. Krechetova, Valentine V. Vtorushina, Mziya I. Makieva, Victor V. Zubkov |
| 69 |
[GO] |
2023―Apr―01 |
SARS-CoV-2 collective immunity among the population of the Republic of Armenia |
Anna Yu. Popova, Vyacheslav S. Smirnov, Svetlana A. Egorova, Artavazd V. Vanyan, Angelika M. Milichkina, Nune G. Bakunts, et al. (+13) Irina V. Drozd, Romella A. Abovyan, Valeriy A. Ivanov, Gayane G. Melik-Andreasyan, Edward Smith Ramsay, Gennady O. Palozyan, Tatyana V. Arbuzova, Ara Sh. Keshishyan, Ouna B. Zhimbayeva, Olga A. Petrova, Alexandra V. Gubanova, Alexandra P. Razumovskaya, Areg A. Totolian |
| 70 |
[GO] |
2023―Apr―01 |
A clinical case of SARS-CoV-2 infection complicated by nephrogenic pulmonary edema and COVID-associated pneumonitis, alveolitis |
Olga V. Vorobeva, Natalya E. Gimaldinova, L. P. Romanova |
| 71 |
[GO] |
2023―Mrz―20 |
COLONIZATION AND AZOLE RESISTANCE OF OROPHARYNGEAL CANDIDA FUNGI IN INTENSIVE CARE PATIENTS WITH COVID-19 |
Svetlana Lisovskaya, Guzel Shavkhatovna Isaeva, Irina Nikolaeva, Sophia Guseva, Lily Gainatullina, Nikita Chumarev |
| 72 |
[GO] |
2023―Mrz―16 |
A CLINICAL CASE OF VIRAL-BACTERIAL PNEUMONIA CAUSED BY SARS-COV-2 AND KLEBSIELLA PNEUMONIAE, COMPLICATED BY A GENERALIZED INFECTION WITH DEVELOPED SEPTICEMIA |
Lubov Petrovna Romanova, Olga Vasilevna Vorobeva |
| 73 |
[GO] |
2023―Mrz―07 |
Assessment of the formation and intensity of adaptive immunity in patients with COVID-19 |
Inna Ivanova, Anna Filippenko, Anastasia Trufanova, Natalya Omelchenko, Olga Chemisova, Aleksej Vodopyanov, et al. (+4) Elena Bereznyak, Elena Sokolova, Aleksej Noskov, Areg Artemovich Artemovich Totolyan |
| 74 |
[GO] |
2023―Mrz―07 |
Clinical case of severe course of Covid-19 in a child with morbid obesity |
Kirill Vladimirovich Samoylov, Yuliya Alexandrovna Ermolaeva, Daria Alekseevna Ponomareva, Anastasiya Aleksandrovna Khudyakova, Anzhelika Vladimirovna Protsenko |
| 75 |
[GO] |
2023―Mrz―07 |
FOURTH ETHICAL COMMENTS TOWARDS COVID-19 (three year later) - Trust and Faith / social and moral profile of vaccination |
Olga Kubar, Galina Mikirtichan |
| 76 |
[GO] |
2023―Mrz―07 |
THE ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS)
IN THE IMMUNOPATHOGENESIS OF SEVERE COVID-19: POTENTIAL IMMUNOTHERAPEUTIC STRATEGIES REGULATING NET FORMATION AND ACTIVITY |
Irina Vadimovna Nesterova, Margarita Galimovna Atazhakhova, Yuri Valerieviсh Teterin, Valeriya Aleksandrovna Matushkina, Galina Anatolievna Chudilova, Marina Nikolaevna Mitropanova |
| 77 |
[GO] |
2023―Mrz―07 |
INVESTIGATING ANTIGENIC FEATURES OF THE SARS-COV-2 ISOLATED IN RUSSIAN FEDERATION IN 2021-2022 BY HYPERIMMUNE MOUSE SERUM NEUTRALISATION |
Anna V. Zaykovskaya, Vasily A. Evseenko, Sergey Е. Olkin, Oleg V. Pyankov |
| 78 |
[GO] |
2023―Mrz―07 |
DYNAMICS IN MATURATION OF SARS-COV-2 RBD-SPECIFIC IGG ANTIBODY AVIDITY DEPENDING ON IMMUNIZATION TIMEFRAME AND TYPE |
Alexandra Mikhailovna Kudryashova, Victor Aleksandrovich Manuylov, Alyona Andreevna Murzina, Alla Nikolaevna Kaira, Olga Vasilievna Borisova |
| 79 |
[GO] |
2023―Mrz―07 |
Maintaining immunological memory to the SARS-CoV-2 virus during a pandemic |
A. Toptygina, Z. Afridonova, R. Zakirov, E. Semikina |
| 80 |
[GO] |
2022―Nov―24 |
DYNAMICS OF CLINICAL SYMPTOMS AND SECRETORY IMMUNOGLOBULIN A IN COVID-19 CONVALESCENT PATIENTS |
Albina А. Khasanova, Mikhail P. Kostinov, Irina L. Soloveva, Tatyana N. Nikitina, Ekaterina A. Khromova |
| 81 |
[GO] |
2022―Nov―24 |
Predictive value of specific cytokines for lethal COVID-19 outcome |
N. A. Arsentieva, N. E. Liubimova, O. K. Batsunov, Z. R. Korobova, R. N. Kuznetsova, A. A. Rubinstein, et al. (+10) O. V. Stanevich, A. A. Lebedeva, E. A. Vorobyov, S. V. Vorobyova, A. N. Kulikov, E. G. Gavrilova, D. E. Pevtcov, Yu. S. Polushin, I. V. Shlyk, A. A. Totolian |
| 82 |
[GO] |
2022―Nov―24 |
EVALUATION OF THE IMPLEMENTATION OF PREVENTION AND INFECTION CONTROL PROGRAMS IN ARMENIAN HOSPITALS DURING THE COVID-19 PANDEMIC |
G. Palozyan, Sh. Avetisyan, R. Abovyan, G. Melik-Andreasyan, A. Vanyan |
| 83 |
[GO] |
2022―Nov―24 |
EPIDEMIOLOGY AND COURSE OF INFECTIOUS DISEASES DURING THE COVID-19 PANDEMIC. REPORT 2: REALIZATION OF INTERFERENCE BETWEEN SARS-COV-2 AND ACUTE RESPIRATORY VIRAL INFECTIONS |
Nikolay A. Belyakov, Ekaterina V. Boeva, Olga E. Simakina, Daria M. Danilenko, Dmitry A. Lioznov |
| 84 |
[GO] |
2022―Nov―24 |
Associations between serum levels of C3, C4, and total classical complement activity in COVID-19 patients at the time of admission and clinical outcome |
A. Razi, A. Azimian, R. Arezumand, A. Solati, H. N. Ahmadabad |
| 85 |
[GO] |
2022―Sep―11 |
Opportunities for correction of immunosuppression in patients with COVID-19 |
Mikhail V. Kiselevskiy, H. M. Treshalina, I. N. Mikhailova, D. V. Martirosyan, I. V. Manina, V. V. Reshetnikova, I. G. Kozlov |
| 86 |
[GO] |
2022―Sep―11 |
A case of abscessed pneumonia due to COVID-19 infection in a young patient |
Olga V. Vorobeva, L. P. Romanova |
| 87 |
[GO] |
2022―Sep―11 |
Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis c and tuberculosis |
Nikolay A. Belyakov, Ekaterina V. Boeva, Zinaida M. Zagdyn, Elena V. Esaulenko, Dmitry A. Lioznov, Olga E. Simakina |
| 88 |
[GO] |
2022―Sep―11 |
Clinical case of rhino-orbital mucormycosis in a convalescent COVID-19 patient: diagnostic and treatment tactics |
Anna Yu. Popova, Yulia V. Demina, Natalya N. Zaytseva, Natalya S. Kucherenko, Arkadyi N. Denisenko, Anna G. Tochilina, et al. (+5) Irina V. Belova, Grigoryi A. Belozerov, Anastasia V. Polyanina, Natalya A. Sadykova, Irina V. Soloveva |
| 89 |
[GO] |
2022―Sep―11 |
Diagnostics of macrophage activation syndrome, depending on IL-6 initial level in patients with a novel coronavirus infection |
Svetlana A. Perepelitsa |
| 90 |
[GO] |
2022―Sep―11 |
Characteristics of respiratory tract bacterial microflora detected in patients suffering from community-acquired pneumonia during continuing spread of the new coronavirus infection in Khabarovsk city (december 2020 - march 2021) |
Olga E. Trotsenko, Albina P. Bondarenko, Vlada A. Shmylenko, Elena A. Bazykina, Natalia Yu. Pshenichnaya, Tatiana A. Zaitseva, et al. (+2) Natalia K. Tkacheva, Olga N. Ogienko |
| 91 |
[GO] |
2022―Sep―11 |
Characterizing A “N-CoV-2-IgG PS” diagnostic kit to quantify SARS-CoV-2 nucleocapsid protein-specific human IgG antibodies |
Elena V. Zueva, Nikolai N. Belyaev, Vyacheslav N. Verbov, Ivan V. Likhachev, Igor A. Bachinin, Irina V. Khamitova, et al. (+3) Zoya R. Korobova, Natalya A. Arsentieva, Areg A. Totolian |
| 92 |
[GO] |
2022―Sep―11 |
Intra-laboratory validated “TigraTest® SARS-CoV-2” - test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens |
Ivan V. Lyagoskin, Pauline E. Kargopolova, Dmitry A. Obyedkov, Irina Yu. Egorova, Rahim R. Shukurov |
| 93 |
[GO] |
2022―Sep―11 |
Assessing SARS-CoV-2-related mortality rate in Russian regions, based on the econometric model |
Vladimir S. Stepanov |
| 94 |
[GO] |
2022―Jul―05 |
The clinical case: COVID-19 in a child with chronic kidney disease |
Yuliya A. Ermolaeva, Yu. G. Samoilova, O. A. Oleynik, D. A. Kudlay |
| 95 |
[GO] |
2022―Mai―12 |
T HELPER CELL SUBSETS AND THEIR TARGET CELLS IN ACUTE COVID-19 |
I. Kudryavtsev, A. Golovkin, A. Totolian |
| 96 |
[GO] |
2022―Mai―12 |
PATHOMORPHOLOGICAL FEATURES OF ARDS IN COMPETING LUNG DISEASES: COVID-19 AND SARCOIDOSIS |
О. V. Vorobeva, N. E. Gimaldinova, L. P. Romanova |
| 97 |
[GO] |
2022―Mai―12 |
Comparison of the humoral and cellular immunity in COVID-19 convalescents |
Anna P. Toptygina, Elena L. Semikina, Rustam Sh. Zakirov, Zulfiia E. Afridonova |
| 98 |
[GO] |
2022―Mai―12 |
FEATURES OF THE NEW CORONAVIRUS INFECTION COVID-19 IN IDENTICAL TWINS |
S. Yudina, V. Kiseleva, T. Rusanova, I. Ivanova |
| 99 |
[GO] |
2022―Mai―12 |
RESISTANCE FACTORS OF KLEBSIELLA PNEUMONIAE BACTERIA DURING COVID-19 PANDEMIC |
O. N. Kolotova, L. V. Kataeva, I. V. Bakshtanovskaya, K. B. Stepanova, T. F. Stepanova |
| 100 |
[GO] |
2022―Mai―12 |
RHINO- AND RS-VIRUSES IN THE COVID-19 PANDEMIC |
I. V. Kiseleva, A. D. Ksenafontov |
| 101 |
[GO] |
2022―Mai―12 |
EVALUATION OF SERUM LEVELS OF IL-6 AND ADIPONECTIN IN COVID-19 PATIENTS AND THEIR RELATIONSHIP WITH DISEASE SEVERITY |
M. Norouzian, Khojasteh Sharifi-Sarasiabi, Majid Najafi-Asl, M. Hassani Azad, H. Estabraghnia Babaki |
| 102 |
[GO] |
2022―Mai―12 |
Local and systemic adverse reactions following COVID-19 vaccine (clinical report) |
N. Yu. Zherebtsova, T. V. Kajdanek |
| 103 |
[GO] |
2022―Mai―12 |
QUANTITATIVE AND QUALITATIVE COMPOSITION OF LYMPHOCYTE POPULATIONS AND SUBSETS IN PATIENTS WITH VARYING SEVERITY OF A NEW CORONAVIRUS INFECTION |
I. A. Ivanova, A. A. Trufanova, A. V. Filippenko, N. D. Omelchenko, A. K. Noskov, O. S. Chemisova |
| 104 |
[GO] |
2022―Mai―12 |
EVALUATION OF THE TWO IN-PATIENT HOSPITALS ON POTENTIAL ENVIRONMENTAL HAZARD DURING THE PERIOD OF NEW CORONAVIRUS INFECTION IN THE KHABAROVSK CITY (DECEMBER 2020 - MARCH 2021) |
O. E. Trotsenko, A. P. Bondarenko, N. Y. Pshenichnaya, T. A. Zaitseva, Y. A. Garbuz, I. V. Chishagorova, et al. (+3) V. A. Shmylenko, E. A. Bazykina, O. N. Ogienko |
| 105 |
[GO] |
2022―Mai―12 |
Anti-interferon alpha autoantibodies and their significance in COVID-19 |
S. S. Petrikov, N. V. Borovkova, K. A. Popugaev, Mayya V. Storozheva, A. M. Kvasnikov, M. A. Godkov |
| 106 |
[GO] |
2022―Mai―12 |
The third ethical commentary to COVID-19 (two years later) - vaccination, solidarity, and trust |
O. I. Kubar, G. L. Mikirtichan, E. Yu. Vladimirova, T. G. Taghi-zade, F. M. Mamedova, U. K. Gadgieva, et al. (+8) S. A. Davtyan, F. M. Mavsisyan, U. M. Tilekeeva, R. K. Gramma, F. Yu. Nasyrova, F. H. Tishkova, Z. M. Mukhamedova, F. S. Atamuradova |
| 107 |
[GO] |
2022―Mrz―14 |
Etiological pattern of community-acquired pneumonia related to the new coronavirus infection COVID-19 pandemic in the Saratov Region |
S. A. Portenko, E. S. Kazakova, E. V. Naidenova, N. A. Osina, M. V. Proskuriakova, A. D. Katyshev, et al. (+11) E. A. Sharkova, O. V. Kedrova, E. A. Chumachkova, M. R. Shamyunov, V. F. Kharitonova, L. A. Gureva, N. Yu. Popova, L. V. Maksimova, S. A. Bugorkova, S. A. Scherbakova, V. V. Kutyrev |
| 108 |
[GO] |
2022―Mrz―14 |
Revealing measles cases in Vietnam during the spread of a new coronavirus infection |
I. N. Lavrentieva, M. Hoang, A. Y. Antipova, M. A. Bichurina, A. A. Totolyan |
| 109 |
[GO] |
2022―Mrz―14 |
<i>In vitro</i> antiviral activity of VIFERON® rectal suppositories against SARS-CoV-2 |
I. N. Isakova-Sivak, E. A. Stepanova, L. G. Rudenko, M. S. Bartov, E. N. Vyzhlova, V. V. Malinovskaya |
| 110 |
[GO] |
2021―Dez―15 |
Differential and diagnostic significance of monocytosis in treatment of moderate forms of COVID-19 |
M. Shperling, E. Shperling, A. Kovalev, A. Vlasov, A. Polyakov, Ya. Noskov, et al. (+4) A. Morozov, V. Merzlyakov, D. Zvyagintsev, V. Tishko |
| 111 |
[GO] |
2021―Dez―15 |
Gender-Related Response of Body Systems in COVID-19 Affects Outcome |
M. Khaksari, N. Sabet, Z. Soltani, H. Bashiri |
| 112 |
[GO] |
2021―Dez―15 |
INFLUENCE OF ULTRAVIOLET BLOOD IRRADIATION ON COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA |
I. Khodza, P. Puzdryak, P Bondarenko, A. Degtyarev, A. Erofeev, K. Chizhova, et al. (+2) V. Shlomin, E. Vedernikova |
| 113 |
[GO] |
2021―Dez―15 |
SALIENT FEATURES OF CIRCULATING RESPIRATORY VIRUSES IN THE PRE- AND PANDEMIC INFLUENZA AND COVID-19 SEASONS |
I. V. Kiseleva, N. V. Larionova, E. P. Grigorieva, A. D. Ksenafontov, M. Al Farroukh, L. G. Rudenko |
| 114 |
[GO] |
2021―Dez―15 |
The correlation between RAS and COVID-19, short review of the latest evidence |
F. Ferrara, A. Vitiello |
| 115 |
[GO] |
2021―Dez―15 |
IMMUNOGRAPH-BASED ANALYSIS OF THE INFLUENZA A (H1N1)PDM09 VACCINE STRAIN IMMUNOGENICITY IN THE PANDEMIC AND POST-PANDEMIC PERIOD (2009-2014) |
V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, et al. (+4) L. V. Lyalina, V. A. Marchenko, I. Yu. Nikonorov, M. P. Grudinin |
| 116 |
[GO] |
2021―Nov―22 |
Study of features of humoral immune response to the new coronavirus infection COVID-19 among healthcare workers |
I. D. Reshetnikova, Yu. A. Tyurin, E. V. Agafonova, S. N. Kulikov, G. F. Gilyazutdinova, D. V. Lopushov, et al. (+3) N. D. Shaуkhrazieva, G. Sh. Isaeva, V. B. Ziatdinov |
| 117 |
[GO] |
2021―Nov―22 |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
A. Yu. Popova, A. A. Tarasenko, V. Yu. Smolensky, S. A. Egorova, V. S. Smirnov, A. M. Dashkevich, et al. (+37) T. N. Svetogor, I. N. Glinskaya, A. L. Skuranovich, A. M. Milichkina, A. M. Dronina, E. O. Samoilovich, I. V. Khamitova, G. V. Semeiko, T. V. Amvrosyeva, N. P. Shmeleva, L. V. Rubanik, O. P. Esmanchik, I. A. Karaban, V. G. Drobyshevskaya, G. V. Sadovnikova, M. V. Shilovich, E. A. Podushkina, V. V. Kireichuk, O. A. Petrova, S. V. Bondarenko, I. F. Salazhkova, L. M. Tkach, L. P. Shepelevich, N. L. Autukhova, V. M. Ivanov, A. S. Babilo, M. V. Navyshnaya, N. N. Belyaev, E. V. Zueva, L. A. Volosar, V. N. Verbov, I. V. Likhachev, T. O. Zagorskaya, N. F. Morozova, Z. R. Korobova, A. V. Gubanova, A. A. Totolian |
| 118 |
[GO] |
2021―Sep―21 |
COVID-19 as a zoonotic infection |
A. N. Kulichenko, O. V. Maletskaya, N. S. Sarkisyan, A. S. Volynkina |
| 119 |
[GO] |
2021―Sep―21 |
Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic |
A. Yu. Popova, A. A. Totolian |
| 120 |
[GO] |
2021―Mrz―24 |
Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation |
A. Yu. Popova, E. E. Andreeva, E. A. Babura, S. V. Balakhonov, N. S. Bashketova, M. V. Bulanov, et al. (+27) N. N. Valeullina, D. V. Goryaev, N. N. Detkovskaya, E. B. Ezhlova, N. N. Zaitseva, O. A. Istorik, I. V. Kovalchuk, D. N. Kozlovskikh, S. V. Kombarova, O. P. Kurganova, V. V. Kutyrev, A. E. Lomovtsev, L. A. Lukicheva, L. V. Lyalina, A. A. Melnikova, O. M. Mikailova, A. K. Noskov, L. N. Noskova, E. E. Oglezneva, T. P. Osmolovskay, M. A. Patyashina, N. A. Penkovskaya, L. V. Samoilova, V. S. Smirnov, T. F. Stepanova, O. E. Trotsenko, Areg A. Totolyan |
| 121 |
[GO] |
2021―Mrz―24 |
A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18-60 years (phase I-II) |
A. B. Ryzhikov, Е. А. Ryzhikov, M. P. Bogryantseva, S. V. Usova, E. D. Danilenko, E. A. Nechaeva, et al. (+17) O. V. Pyankov, O. G. Pyankova, A. S. Gudymo, S. A. Bodnev, G. S. Onkhonova, E. S. Sleptsova, V. I. Kuzubov, N. N. Ryndyuk, Z. I. Ginko, V. N. Petrov, A. A. Moiseeva, P. Yu. Torzhkova, S. A. Pyankov, T. V. Tregubchak, D. V. Antonec, E. V. Gavrilova, R. A. Maksyutov |
| 122 |
[GO] |
2021―Mrz―02 |
Second ethical comments towards COVID-19 (one year later) |
O. I. Kubar, M. A. Bichurina, N. I. Romanenkova |
| 123 |
[GO] |
2020―Sep―28 |
Parthenolide: suggested drug for COVID-19 |
M. Nemati, F. Danesh Pouya, E. Roshani Asl, Y. Rami |
| 124 |
[GO] |
2020―Sep―28 |
THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW OF THE CURRENT EVIDENCE |
R. Ghomi, N. Asgari, A. Hajiheydari, R. Esteki, F. Biyabanaki, F. Nasirinasab |
| 125 |
[GO] |
2020―Aug―08 |
Organ-specific pathomorphological changes during COVID-19 |
O. V. Vorobeva, A. V. Lastochkin |
| 126 |
[GO] |
2020―Aug―08 |
COVID-19 and BCG vaccine: is there a link? |
I. V. Lyadova, A. A. Starikov |
| 127 |
[GO] |
2020―Aug―08 |
Lessons to learn: COVID-19 epidemic in Italy |
A. V. Semenov, N. Y. Pshenichnaya |
| 128 |
[GO] |
2020―Aug―08 |
COVID-19: etiology, clinical picture, treatment |
M. Yu. Shchelkanov, L. V. Kolobukhina, O. A. Burgasova, I. S. Kruzhkova, V. V. Maleev |
| 129 |
[GO] |
2020―Aug―08 |
Some opportunities for immunotherapy in coronavirus infection |
V. S. Smirnov, Areg A. Totolian |
| 130 |
[GO] |
2020―Mai―22 |
An early assessment of the efficacy of medicines in the treatment of patients with COVID-19 |
A. S. Kolbin |
| 131 |
[GO] |
2020―Mai―22 |
COVID-19: an updated review |
F. A. Isihak, M. A. Hamad, N. G. Mustafa |
| 132 |
[GO] |
2020―Apr―12 |
INNATE IMMUNITY IN CORONAVIRUS INFECTION |
V. Smirnov, A. Totolyan |
| 133 |
[GO] |
2020―Apr―12 |
THE HISTORY OF INVESTIGATION AND MODERN CLASSIFICATION OF CORONAVIRUSES (NIDOVIRALES: CORONAVIRIDAE) |
M. Yu. Shchelkanov, A. Yu. Popova, V. G. Dedkov, V. G. Akimkin, V. V. Maleyev |
|
